Table 1 Main clinical findings from (a) CLL (98 patients) and (b) MCL (64 patients)

From: TCL1A expression delineates biological and clinical variability in B-cell lymphoma

Clinical variables

Total

(a) CLL

 

 Sex

 

Male

60

Female

38

 Age at diagnosis (year)a

 

<60

34

60–69

30

70

32

 RAI stage

 

0

52

>0

46

 Binet stage

 

A

76

B+C

22

 CD38 expressiona

 

<20%

65

20%

23

 First-line treatment (at 60 months of follow-up)

 

Yes

43

No

55

(b) MCL

 

 Sex

 

Male

45

Female

19

 Agea

 

<60 years

21

60 years

30

 Stagesa

 

I

0

II

4

III

7

IV

48

 Extranodal involvementa

 

<2

39

2

25

 Serum LDHa

 

Normal

38

>Normal

12

 ECOG performance statusa

 

<2

42

2

11

 International prognostic indexa

 

Low/low-intermediate

27

High/high-intermediate

25

 Overall survival (at 60 months)

 

Alive

36

Dead

28

  1. CLL, chronic lymphocytic leukemia; ECOG, Eastern Cooperative Oncology Group; LDH, lactate dehydrogenase; MCL, mantle cell lymphoma.
  2. aData are not available for all the cases.